Krilogy Financial LLC Exact Sciences Corp Transaction History

Krilogy Financial LLC

$1.35 Billion
Q3 2024

A detailed history of Krilogy Financial LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Krilogy Financial LLC holds 24,783 shares of EXAS stock, worth $1.42 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

24,783

Previous 30,765 19.44%

Holding current value

$1.42 Million

Previous $1.3 Million 29.87%

% of portfolio

0.13%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$42.43 - $70.83 $253,816 - $423,705	-5,982 Reduced 19.44%	24,783 $1.69 Million
Q2 2024 Jul 22, 2024	BUY	$41.33 - $74.26 $159,161 - $285,975	3,851 Added 14.31%	30,765 $1.3 Million
Q1 2024 Apr 24, 2024	BUY	$56.27 - $73.77 $413,021 - $541,471	7,340 Added 37.5%	26,914 $1.86 Million
Q4 2023 Jan 26, 2024	SELL	$59.06 - $75.72 $165,368 - $212,016	-2,800 Reduced 12.51%	19,574 $1.45 Million
Q3 2023 Nov 01, 2023	BUY	$65.94 - $99.04 $673,577 - $1.01 Million	10,215 Added 84.01%	22,374 $1.53 Million
Q2 2023 Jul 19, 2023	SELL	$62.68 - $95.05 $373,322 - $566,117	-5,956 Reduced 32.88%	12,159 $1.14 Million
Q1 2023 May 03, 2023	BUY	$47.19 - $70.77 $268,794 - $403,105	5,696 Added 45.87%	18,115 $1.23 Million
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $150,293 - $263,198	-4,952 Reduced 28.51%	12,419 $614,000
Q3 2022 Oct 06, 2022	SELL	$31.97 - $49.37 $31 - $49	-1 Reduced 0.01%	17,371 $564,000
Q2 2022 Jul 14, 2022	BUY	$35.61 - $76.23 $467,879 - $1 Million	13,139 Added 310.39%	17,372 $684,000
Q1 2022 Apr 28, 2022	SELL	$57.56 - $82.54 $623,087 - $893,495	-10,825 Reduced 71.89%	4,233 $296,000
Q4 2021 Jan 27, 2022	BUY	$72.5 - $100.68 $353,800 - $491,318	4,880 Added 47.95%	15,058 $1.17 Million
Q3 2021 Oct 25, 2021	BUY	$90.24 - $124.05 $63,799 - $87,703	707 Added 7.46%	10,178 $971,000
Q2 2021 Jul 20, 2021	BUY	$93.66 - $139.27 $21,354 - $31,753	228 Added 2.47%	9,471 $1.18 Million
Q1 2021 Apr 21, 2021	BUY	$116.57 - $155.01 $59,567 - $79,210	511 Added 5.85%	9,243 $1.22 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $11,753 - $16,770	-118 Reduced 1.33%	8,732 $1.16 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $7,437 - $10,405	-102 Reduced 1.14%	8,850 $902,000
Q2 2020 Aug 06, 2020	SELL	$55.75 - $92.75 $651,773 - $1.08 Million	-11,691 Reduced 56.63%	8,952 $778,000
Q1 2020 May 13, 2020	BUY	$37.9 - $104.44 $782,369 - $2.16 Million	20,643 New	20,643 $1.2 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $11,208 - $16,532	-200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $9,658 - $16,119	200 New	200 $16,000
Q2 2018 Aug 15, 2018	SELL	$37.84 - $69.96 $64,328 - $118,931	-1,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $15,928 - $23,012	400 Added 30.77%	1,700 $69,000
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $4,649 - $6,051	100 Added 8.33%	1,300 $68,000
Q3 2017 Nov 15, 2017	SELL	$37.05 - $47.12 $100,034 - $127,224	-2,700 Reduced 69.23%	1,200 $57,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,900	3,900 $138,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Account

Krilogy Financial LLC Exact Sciences Corp Transaction History